These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1803509)

  • 1. Absorption through the peritoneum of the macromolecular profibrinolytic drug defibrotide in the rabbit.
    Porta R; Calvani AB; Pescador R; Mantovani M; Prino G
    Semin Thromb Hemost; 1991 Oct; 17(4):404-6. PubMed ID: 1803509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on pharmacokinetics of radioactive labelled defibrotide after oral or intravenous administration in rats.
    Fisher J; Holland TK; Pescador R; Porta R; Ferro L
    Thromb Res; 1996 Jan; 81(1):55-63. PubMed ID: 8747520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated view of the activities of defibrotide.
    Pescador R; Porta R; Ferro L
    Semin Thromb Hemost; 1996; 22 Suppl 1():71-5. PubMed ID: 8807733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, absorption, distribution and disposition of [125I]-defibrotide following intravenous or oral administration in the rat.
    Fisher J; Johnston AM; Holland TK; McCallum J; Pescador R; Mantovani M; Prino G
    Thromb Res; 1993 Apr; 70(1):77-90. PubMed ID: 8511753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography determination of polydeoxyribonucleotides in plasma: its application to the determination of defibrotide's pharmacokinetics in the rabbit.
    Porta R; Moltrasio D; Pescador R; Lanzarotti E; Mantovani M; Prino G
    Anal Biochem; 1992 Jul; 204(1):143-6. PubMed ID: 1514679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
    Berti F; Rossoni G; Niada R; Omini C; Pretolani M; Mandelli C
    Haemostasis; 1986; 16 Suppl 1():13-7. PubMed ID: 3011616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel insight into the mechanism of the antithrombotic action of defibrotide.
    Tettamanti R; Bianchi G; Vitte PA; Kato G; Porta R; Thiemermann C; Pescador R; Mantovani M
    Life Sci; 1992; 51(19):1545-55. PubMed ID: 1331634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit.
    Pescador R; Mantovani M; Prino G; Madonna M
    Thromb Res; 1983 Apr; 30(1):1-11. PubMed ID: 6687960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrotide is antithrombotic and thrombolytic against rabbit venous thrombosis.
    Niada R; Pescador R; Porta R; Mantovani M; Prino G
    Haemostasis; 1986; 16 Suppl 1():3-8. PubMed ID: 3519381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology and clinical pharmacology of defibrotide: a new profibrinolytic, antithrombotic and anti-platelet substance.
    Ulutin ON; Balkuv-Ulutin S; Ugur MS; Ulutin T; Ozsoy Y; Cizmeci G
    Adv Exp Med Biol; 1990; 281():429-38. PubMed ID: 2102624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrotide, an antithrombotic substance that preserves postsynaptic alpha- and beta-adrenergic function in post acute infarcted rabbit hearts.
    Berti F; Rossoni G; Niada R; Folco G; Omini C; Tondo C
    J Cardiovasc Pharmacol; 1986; 8(2):235-40. PubMed ID: 2422459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrotide reduces monocyte PAI-2 and procoagulant activity.
    Abbate R; Gori AM; Martini F; Attanasio M; Comeglio P; Giusti B; Zarone N; Francalanci I; Prisco D; Gensini GF
    Semin Thromb Hemost; 1995; 21(2):245-50. PubMed ID: 7660147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of superficial vein thrombosis treated with defibrotide: comparison with low dose subcutaneous heparin.
    Belcaro G
    Int J Tissue React; 1990; 12(5):319-24. PubMed ID: 2098372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are increased ATP blood levels responsible for PGI2 release from endothelium?
    Salari PC; Marni A; Parisé M; Calvani AB; Spaggiari PG; Gaja G; Ferrero ME
    Int J Tissue React; 1991; 13(4):219-23. PubMed ID: 1668237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.